Campbell Soup Co. vs Heron Therapeutics Inc — how do they compare? Campbell Soup Co. trades at $22.71 (market cap $6.78B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Campbell Soup Co. is far larger — about 110.3× Heron Therapeutics Inc's market cap, and Campbell Soup Co. pays a 6.87% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| CPB | HRTX | |
|---|---|---|
Market Cap | $6.78B | $61.47M |
Sector | Consumer Staples | Health |
52-Week High | $34.03 | $1.49 |
52-Week Low | $20.00 | $0.32 |
Enterprise Value | $13.38B | $168.21M |
Dividend Yield | 6.87% | — |
Trailing returns across standard periods
Latest headlines on both assets
With a history that dates back around 150 years, Campbell Soup is now a leading manufacturer and marketer of branded convenience food products, most notably soup. The firm's product assortment includes well-known brands like Campbell's, Pace, Prego, Swanson, V8, and Pepperidge Farm. Following the sale of its international snacking operations, which wrapped in calendar 2019, the firm derives nearly all of its sales from its home turf. Campbell has made a handful of acquisitions to reshape its product mix the past few years, including the tie-up with Snyder's-Lance (completed in March 2018), which enhances its exposure to the faster-growing on-trend snack food aisle, complementing its Pepperidge Farm lineup.
Read more on CPB →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →